IMMUNE GLOBULIN INFUSION (HUMAN)

IMMUNE GLOBULIN INFUSION (HUMAN) was reported 8671 times

IMMUNE GLOBULIN INFUSION (HUMAN) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION 56 0.2979
1 ANTI A ANTIBODY POSITIVE 12 0.2182
2 ACUTE HAEMOLYTIC TRANSFUSION REACTION 5 0.1786
3 HAEMOLYTIC TRANSFUSION REACTION 10 0.1538
4 BLOOD BETA-D-GLUCAN ABNORMAL 3 0.1500
5 ANTI-HBC ANTIBODY POSITIVE 4 0.1143
6 ANTI-ERYTHROCYTE ANTIBODY POSITIVE 8 0.0976
7 HYPOTENSIVE TRANSFUSION REACTION 6 0.0909
8 ALLERGIC TRANSFUSION REACTION 13 0.0861
9 ALLERGY TO IMMUNOGLOBULIN THERAPY 9 0.0826
10 RED BLOOD CELL SPHEROCYTES PRESENT 4 0.0702
11 DELAYED HAEMOLYTIC TRANSFUSION REACTION 4 0.0678
12 IMMUNOGLOBULINS ABNORMAL 13 0.0498
13 COOMBS DIRECT TEST POSITIVE 15 0.0481
14 ANTI-HBS ANTIBODY POSITIVE 3 0.0469
15 MENINGITIS ASEPTIC 203 0.0452
16 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 10 0.0413
17 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 13 0.0387
18 HEPATITIS B ANTIBODY POSITIVE 7 0.0372
19 TRANSFUSION-RELATED ACUTE LUNG INJURY 11 0.0357
20 SELECTIVE IGA IMMUNODEFICIENCY 5 0.0340
21 EAR INFECTION VIRAL 4 0.0250
22 INCORRECT DRUG ADMINISTRATION RATE 106 0.0249
23 INFUSION SITE SCAR 11 0.0248
24 BLOOD IMMUNOGLOBULIN A DECREASED 16 0.0246
25 HEPATITIS B SURFACE ANTIBODY POSITIVE 7 0.0240
26 BLOOD IMMUNOGLOBULIN G ABNORMAL 4 0.0240
27 TRANSFUSION REACTION 21 0.0239
28 THYROGLOBULIN INCREASED 4 0.0235
29 INFUSION SITE URTICARIA 14 0.0209
30 INFUSION SITE RASH 28 0.0204
31 INFUSION SITE DISCOMFORT 21 0.0203
32 BODY HEIGHT BELOW NORMAL 13 0.0202
33 INFUSION SITE MASS 21 0.0193
34 INFUSION SITE SWELLING 120 0.0191
35 HEPATITIS B CORE ANTIBODY POSITIVE 7 0.0186
36 COOMBS TEST POSITIVE 5 0.0183
37 IMMUNOGLOBULINS DECREASED 24 0.0175
38 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 8 0.0174
39 BLOOD IMMUNOGLOBULIN G DECREASED 42 0.0169
40 ACUTE HEPATITIS C 3 0.0164
41 INFUSION SITE BRUISING 35 0.0162
42 INFUSION SITE PRURITUS 50 0.0158
43 HEPATITIS B VIRUS TEST POSITIVE 6 0.0157
44 INFUSION SITE WARMTH 18 0.0147
45 IMMUNODEFICIENCY COMMON VARIABLE 7 0.0143
46 ANTIBODY TEST POSITIVE 23 0.0138
47 INFUSION SITE EXTRAVASATION 81 0.0130
48 INFUSION SITE ERYTHEMA 107 0.0127
49 PRODUCT CLOSURE ISSUE 7 0.0126
50 HAEMOLYSIS 90 0.0116
51 ADENOIDAL DISORDER 3 0.0115
52 BLOOD IMMUNOGLOBULIN G INCREASED 14 0.0115
53 FUNGAL TEST POSITIVE 4 0.0114
54 INFUSION SITE REACTION 34 0.0114
55 ANAPHYLACTOID REACTION 46 0.0112
56 ANTI-THYROID ANTIBODY POSITIVE 5 0.0109
57 INFUSION SITE HAEMORRHAGE 33 0.0100
58 INFUSION SITE PAIN 129 0.0100
59 INFUSION SITE IRRITATION 12 0.0093
60 INFUSION SITE DISCHARGE 16 0.0091
61 CROUP INFECTIOUS 7 0.0089
62 INFUSION RELATED REACTION 584 0.0088
63 PRODUCT TEMPERATURE EXCURSION ISSUE 45 0.0087
64 SINUSITIS BACTERIAL 9 0.0085
65 DYSHIDROTIC ECZEMA 6 0.0084
66 JOINT DESTRUCTION 13 0.0084
67 FALSE POSITIVE INVESTIGATION RESULT 8 0.0079
68 DEVICE INFUSION ISSUE 19 0.0077
69 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE 3 0.0076
70 INFUSION SITE VESICLES 4 0.0076
71 VULVAL DISORDER 5 0.0076
72 VENOUS INJURY 7 0.0075
73 INFUSION SITE INDURATION 11 0.0074
74 POOR VENOUS ACCESS 76 0.0073
75 LIVEDO RETICULARIS 15 0.0072
76 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 4 0.0071
77 NO THERAPEUTIC RESPONSE 86 0.0070
78 BLOOD IMMUNOGLOBULIN M DECREASED 7 0.0070
79 JUVENILE IDIOPATHIC ARTHRITIS 17 0.0069
80 INFUSION RELATED HYPERSENSITIVITY REACTION 4 0.0067
81 NUCHAL RIGIDITY 6 0.0066
82 RETICULOCYTE COUNT INCREASED 5 0.0062
83 INSURANCE ISSUE 92 0.0060
84 LYME DISEASE 20 0.0060
85 MENINGITIS 40 0.0060
86 BODY TEMPERATURE ABNORMAL 11 0.0060
87 MULTIMORBIDITY 7 0.0058
88 MENINGITIS VIRAL 8 0.0058
89 CRANIAL NERVE DISORDER 4 0.0057
90 INFUSION SITE INFLAMMATION 4 0.0057
91 SINUSITIS 574 0.0056
92 INABILITY TO AFFORD MEDICATION 55 0.0055
93 LOWER RESPIRATORY TRACT CONGESTION 9 0.0053
94 SINUSITIS FUNGAL 4 0.0050
95 GASTROINTESTINAL VIRAL INFECTION 5 0.0048
96 HAEMOLYTIC ANAEMIA 43 0.0048
97 COVID-19 IMMUNISATION 4 0.0048
98 PERTUSSIS 5 0.0048
99 VEIN RUPTURE 8 0.0048
100 INFECTED BITE 4 0.0047
101 VITAL FUNCTIONS ABNORMAL 4 0.0047
102 CHILLS 542 0.0046
103 INFECTIOUS MONONUCLEOSIS 10 0.0045
104 DRUG SPECIFIC ANTIBODY 6 0.0044
105 DERMATITIS DIAPER 3 0.0042
106 VEIN DISORDER 21 0.0042
107 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 6 0.0042
108 POLYARTHRITIS 22 0.0042
109 ANTIBODY TEST ABNORMAL 3 0.0042
110 SEIZURE LIKE PHENOMENA 7 0.0041
111 HAEMOPHILUS INFECTION 4 0.0041
112 POST-ACUTE COVID-19 SYNDROME 5 0.0040
113 SERUM SICKNESS 11 0.0039
114 RESPIRATORY TRACT INFECTION VIRAL 9 0.0039
115 BREAST FEEDING 3 0.0038
116 BLISTER INFECTED 3 0.0038
117 GASTROENTERITIS NOROVIRUS 5 0.0038
118 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5 0.0037
119 ATYPICAL PNEUMONIA 11 0.0037
120 PRODUCT DISTRIBUTION ISSUE 34 0.0037
121 OXYGEN THERAPY 6 0.0036
122 EAR INFECTION 96 0.0036
123 CRANIOFACIAL FRACTURE 3 0.0035
124 ALLERGIC SINUSITIS 3 0.0035
125 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 8 0.0035
126 HEPATITIS B REACTIVATION 11 0.0035
127 VASCULAR INJURY 5 0.0035
128 CHRONIC SINUSITIS 13 0.0035
129 MULTIPLE ALLERGIES 27 0.0034
130 LIQUID PRODUCT PHYSICAL ISSUE 25 0.0034
131 DARK CIRCLES UNDER EYES 5 0.0034
132 POLYMYOSITIS 6 0.0034
133 WHEELCHAIR USER 15 0.0034
134 BODY TEMPERATURE INCREASED 67 0.0033
135 GASTROENTERITIS VIRAL 59 0.0033
136 UPPER RESPIRATORY TRACT INFECTION 150 0.0032
137 CORONARY ARTERY DISEASE 95 0.0031
138 ANTIPHOSPHOLIPID SYNDROME 5 0.0031
139 ADRENOCORTICAL INSUFFICIENCY ACUTE 6 0.0031
140 OROPHARYNGEAL BLISTERING 5 0.0031
141 RESPIRATORY TRACT INFECTION 78 0.0030
142 DEMYELINATING POLYNEUROPATHY 3 0.0029
143 RHONCHI 4 0.0029
144 SKIN INFECTION 32 0.0028
145 MAST CELL ACTIVATION SYNDROME 4 0.0028
146 TACHYPNOEA 38 0.0028
147 NOROVIRUS INFECTION 4 0.0028
148 BRONCHITIS 205 0.0028
149 OBSTRUCTION 11 0.0028
150 INFECTION SUSCEPTIBILITY INCREASED 6 0.0027
151 EXTRAVASATION 11 0.0027
152 AUTOIMMUNE THYROIDITIS 10 0.0026
153 PROTEIN TOTAL INCREASED 7 0.0026
154 ANIMAL BITE 7 0.0026
155 GASTROINTESTINAL INFECTION 23 0.0026
156 ADRENAL INSUFFICIENCY 31 0.0026
157 VIRAL INFECTION 85 0.0026
158 STREPTOCOCCAL INFECTION 14 0.0025
159 INFECTION 364 0.0025
160 INTENTIONAL PRODUCT USE ISSUE 218 0.0025
161 CYANOSIS 39 0.0025
162 LYMPHADENITIS 6 0.0025
163 PHARYNGITIS STREPTOCOCCAL 26 0.0024
164 MIGRAINE 229 0.0024
165 SINUS DISORDER 47 0.0024
166 NONSPECIFIC REACTION 13 0.0024
167 MYASTHENIA GRAVIS 19 0.0024
168 AMYOTROPHIC LATERAL SCLEROSIS 5 0.0023
169 WOUND INFECTION STAPHYLOCOCCAL 4 0.0023
170 THROMBOPHLEBITIS SUPERFICIAL 7 0.0023
171 ENCEPHALITIS AUTOIMMUNE 3 0.0023
172 MIDDLE EAR EFFUSION 5 0.0023
173 BLOOD POTASSIUM ABNORMAL 6 0.0022
174 FLANK PAIN 21 0.0022
175 CYSTITIS NONINFECTIVE 3 0.0022
176 MYCOBACTERIUM AVIUM COMPLEX INFECTION 6 0.0022
177 ANAPHYLACTIC REACTION 122 0.0022
178 PLEURISY 13 0.0022
179 CEREBROSPINAL FLUID LEAKAGE 4 0.0022
180 AUTOIMMUNE DISORDER 21 0.0022
181 HEART RATE ABNORMAL 12 0.0021
182 OXYGEN SATURATION ABNORMAL 6 0.0021
183 ADRENAL DISORDER 4 0.0021
184 NASAL SEPTUM DEVIATION 4 0.0020
185 KIDNEY INFECTION 40 0.0020
186 DRUG DELIVERY SYSTEM ISSUE 4 0.0020
187 DERMATITIS CONTACT 23 0.0020
188 HEPATITIS B 12 0.0020
189 FIBRIN D DIMER INCREASED 7 0.0020
190 DISEASE COMPLICATION 9 0.0020
191 BRONCHIAL DISORDER 3 0.0019
192 BRONCHIECTASIS 13 0.0019
193 EPSTEIN-BARR VIRUS INFECTION 12 0.0019
194 BACTERIAL VAGINOSIS 3 0.0019
195 SEASONAL ALLERGY 27 0.0019
196 TOOTH INFECTION 25 0.0019
197 RALES 11 0.0019
198 PHARYNGEAL ERYTHEMA 4 0.0019
199 ADVERSE REACTION 25 0.0019
200 PNEUMONIA VIRAL 6 0.0019
201 HYPOXIA 66 0.0019
202 FOOD POISONING 10 0.0019
203 INFLUENZA LIKE ILLNESS 153 0.0019
204 NO ADVERSE EVENT 334 0.0018
205 LIMB MASS 4 0.0018
206 OTITIS MEDIA 6 0.0018
207 RED BLOOD CELL SEDIMENTATION RATE INCREASED 20 0.0018
208 RESPIRATORY RATE INCREASED 16 0.0018
209 FEELING COLD 50 0.0018
210 PHLEBITIS 9 0.0018
211 FINE MOTOR SKILL DYSFUNCTION 5 0.0017
212 HEADACHE 1078 0.0017
213 LOCALISED INFECTION 41 0.0017
214 CHRONIC LYMPHOCYTIC LEUKAEMIA 8 0.0017
215 PRODUCT CONTAMINATION 6 0.0017
216 FOOD ALLERGY 13 0.0017
217 CREPITATIONS 5 0.0017
218 DEVICE ALARM ISSUE 3 0.0017
219 BRONCHITIS CHRONIC 4 0.0016
220 PRODUCT AVAILABILITY ISSUE 37 0.0016
221 PYREXIA 560 0.0016
222 BRONCHOSPASM 23 0.0016
223 BACTERIAL INFECTION 30 0.0016
224 RESPIRATORY SYNCYTIAL VIRUS INFECTION 14 0.0016
225 RENAL PAIN 17 0.0016
226 URINE OUTPUT DECREASED 14 0.0016
227 PHOTOPHOBIA 30 0.0016
228 EYE INFECTION 18 0.0016
229 DRUG TOLERANCE 8 0.0016
230 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
231 VASCULAR DEVICE INFECTION 7 0.0015
232 CATHETER SITE PAIN 4 0.0015
233 EARLY SATIETY 3 0.0015
234 RHINOVIRUS INFECTION 6 0.0015
235 GRAFT VERSUS HOST DISEASE 11 0.0015
236 IMMUNE THROMBOCYTOPENIA 7 0.0015
237 THROMBOSIS IN DEVICE 5 0.0015
238 DIPLEGIA 3 0.0015
239 SUSPECTED COVID-19 5 0.0015
240 TACHYCARDIA 133 0.0015
241 WHITE BLOOD CELL DISORDER 4 0.0015
242 POST PROCEDURAL INFECTION 12 0.0015
243 MIGRAINE WITH AURA 4 0.0015
244 URTICARIA 246 0.0015
245 ORAL FUNGAL INFECTION 4 0.0015
246 OBESITY 23 0.0014
247 PETECHIAE 15 0.0014
248 BLOOD PRESSURE INCREASED 219 0.0014
249 EAR PRURITUS 5 0.0014
250 OXYGEN SATURATION DECREASED 80 0.0014
251 EAR SWELLING 3 0.0014
252 HYPERVOLAEMIA 7 0.0014
253 PROTEIN URINE PRESENT 7 0.0014
254 BLOOD MAGNESIUM DECREASED 12 0.0014
255 HYPERVENTILATION 8 0.0014
256 SPUTUM DISCOLOURED 13 0.0014
257 ADVERSE DRUG REACTION 123 0.0014
258 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
259 STAPHYLOCOCCAL INFECTION 45 0.0014
260 NECK INJURY 4 0.0014
261 ARTHROPOD BITE 10 0.0013
262 CELLULITIS 68 0.0013
263 BACTERIAL TEST POSITIVE 3 0.0013
264 NECK PAIN 75 0.0013
265 IMMUNODEFICIENCY 20 0.0013
266 HEPATITIS C 16 0.0013
267 PARANASAL SINUS DISCOMFORT 5 0.0013
268 CHEST DISCOMFORT 135 0.0013
269 ILLNESS 135 0.0013
270 BLADDER DISORDER 13 0.0013
271 GASTRIC INFECTION 5 0.0013
272 CANDIDA INFECTION 22 0.0013
273 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
274 RESPIRATORY RATE DECREASED 4 0.0013
275 RESPIRATORY DISORDER 38 0.0013
276 INFLUENZA 141 0.0013
277 URINARY TRACT INFECTION 215 0.0013
278 CYSTITIS 40 0.0013
279 TENDERNESS 13 0.0012
280 INCORRECT PRODUCT ADMINISTRATION DURATION 27 0.0012
281 GUILLAIN-BARRE SYNDROME 6 0.0012
282 FUNGAL SKIN INFECTION 5 0.0012
283 WRONG DRUG ADMINISTERED 11 0.0012
284 LIVER ABSCESS 4 0.0012
285 ANTINUCLEAR ANTIBODY POSITIVE 4 0.0012
286 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
287 PALLOR 33 0.0012
288 FUNGAL INFECTION 40 0.0012
289 CATHETER SITE HAEMORRHAGE 3 0.0012
290 PNEUMONIA BACTERIAL 11 0.0012
291 DERMATOMYOSITIS 3 0.0012
292 SINUS HEADACHE 7 0.0012
293 DIABETIC COMPLICATION 3 0.0012
294 ENCEPHALITIS 8 0.0012
295 PRODUCT STORAGE ERROR 100 0.0011
296 PULMONARY MASS 17 0.0011
297 EAR PAIN 22 0.0011
298 NASOPHARYNGITIS 208 0.0011
299 ANAPHYLACTIC SHOCK 29 0.0011
300 BODY TEMPERATURE DECREASED 11 0.0011
301 OVERWEIGHT 6 0.0011
302 FRUSTRATION 4 0.0011
303 DRUG EFFECT DECREASED 60 0.0011
304 SPINAL PAIN 13 0.0011
305 MUSCULOSKELETAL DISCOMFORT 19 0.0011
306 BLOOD PRESSURE DECREASED 73 0.0011
307 DRUG INTOLERANCE 106 0.0011
308 POST PROCEDURAL COMPLICATION 21 0.0011
309 EAR DISORDER 5 0.0011
310 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 196 0.0011
311 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
312 ARTHRITIS INFECTIVE 5 0.0011
313 THROAT TIGHTNESS 29 0.0011
314 PNEUMONIA 347 0.0011
315 ELECTRIC SHOCK SENSATION 3 0.0011
316 ACUTE PULMONARY OEDEMA 6 0.0011
317 CEREBRAL THROMBOSIS 3 0.0011
318 CHEMOTHERAPY 4 0.0011
319 BACK PAIN 245 0.0011
320 SARCOIDOSIS 5 0.0011
321 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
322 WEIGHT FLUCTUATION 11 0.0011
323 PSEUDOMONAS INFECTION 9 0.0010
324 PARANASAL SINUS HYPERSECRETION 4 0.0010
325 HERPES VIRUS INFECTION 6 0.0010
326 RHEUMATOID FACTOR POSITIVE 6 0.0010
327 CONCUSSION 8 0.0010
328 JOINT INJURY 22 0.0010
329 LUNG INFECTION 16 0.0010
330 MALAISE 450 0.0010
331 COLD SWEAT 18 0.0010
332 ENERGY INCREASED 6 0.0010
333 LYMPHOEDEMA 7 0.0010
334 RESPIRATORY TRACT CONGESTION 16 0.0010
335 PRODUCT SUPPLY ISSUE 7 0.0010
336 ESCHERICHIA INFECTION 8 0.0010
337 PHOTOSENSITIVITY REACTION 16 0.0010
338 NEEDLE ISSUE 28 0.0010
339 LYMPHADENOPATHY 34 0.0010
340 BLOOD BLISTER 3 0.0010
341 MALABSORPTION 5 0.0010
342 THROMBOSIS 77 0.0010
343 LEUKAEMIA 9 0.0010
344 IMPAIRED GASTRIC EMPTYING 13 0.0010
345 SYNOVITIS 17 0.0009
346 RESPIRATORY DISTRESS 26 0.0009
347 PRODUCT CONTAINER ISSUE 8 0.0009
348 COVID-19 PNEUMONIA 11 0.0009
349 FLUSHING 93 0.0009
350 WOUND INFECTION 10 0.0009
351 BEDRIDDEN 12 0.0009
352 PROCEDURAL COMPLICATION 7 0.0009
353 WALKING AID USER 6 0.0009
354 BLOOD PRESSURE ABNORMAL 18 0.0009
355 FACIAL PAIN 8 0.0009
356 BLOOD URINE PRESENT 17 0.0009
357 HYPERSENSITIVITY 165 0.0009
358 SINUS CONGESTION 12 0.0009
359 PERONEAL NERVE PALSY 5 0.0009
360 ASTHMA 99 0.0009
361 JOINT EFFUSION 6 0.0009
362 WHEEZING 51 0.0009
363 LOCAL SWELLING 15 0.0009
364 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
365 POOR QUALITY PRODUCT ADMINISTERED 9 0.0009
366 EXPOSURE DURING PREGNANCY 53 0.0009
367 VAGINAL INFECTION 4 0.0008
368 HEREDITARY ANGIOEDEMA 9 0.0008
369 TREMOR 139 0.0008
370 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 6 0.0008
371 HEART RATE INCREASED 82 0.0008
372 SKIN LACERATION 9 0.0008
373 RASH VESICULAR 4 0.0008
374 COVID-19 145 0.0008
375 HYPERTENSION 174 0.0008
376 HERPES ZOSTER 47 0.0008
377 SENSITIVE SKIN 6 0.0008
378 FOOT DEFORMITY 9 0.0008
379 BREATH SOUNDS ABNORMAL 4 0.0008
380 STAPHYLOCOCCAL SEPSIS 4 0.0008
381 VOMITING 379 0.0008
382 ACUTE HEPATIC FAILURE 11 0.0008
383 PNEUMONIA ASPIRATION 20 0.0008
384 GROIN PAIN 7 0.0008
385 CATHETER SITE INFECTION 3 0.0008
386 SCAB 9 0.0008
387 TROPONIN INCREASED 6 0.0008
388 MASS 11 0.0008
389 HYPERTHERMIA 6 0.0008
390 SCREAMING 5 0.0008
391 DEVICE RELATED INFECTION 12 0.0008
392 EAR DISCOMFORT 8 0.0008
393 THYROID DISORDER 12 0.0008
394 MUSCULOSKELETAL STIFFNESS 68 0.0008
395 LIMB DISCOMFORT 24 0.0008
396 CHEST PAIN 143 0.0008
397 ORAL HERPES 15 0.0008
398 SPLENOMEGALY 9 0.0008
399 OROPHARYNGEAL PAIN 71 0.0008
400 TONSILLITIS 4 0.0008
401 NODULE 10 0.0008
402 ORAL CANDIDIASIS 10 0.0008
403 SARS-COV-2 TEST POSITIVE 10 0.0008
404 PRODUCTIVE COUGH 36 0.0008
405 DYSPNOEA 422 0.0007
406 NAUSEA 590 0.0007
407 LACERATION 7 0.0007
408 HEAD DISCOMFORT 13 0.0007
409 RASH GENERALISED 19 0.0007
410 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
411 MATERNAL EXPOSURE BEFORE PREGNANCY 5 0.0007
412 HYPERAESTHESIA 6 0.0007
413 TENDON RUPTURE 9 0.0007
414 GENERALISED OEDEMA 9 0.0007
415 SPINAL COMPRESSION FRACTURE 6 0.0007
416 PHARYNGITIS 9 0.0007
417 DROOLING 5 0.0007
418 LIP SWELLING 24 0.0007
419 THROMBOTIC MICROANGIOPATHY 7 0.0007
420 FATIGUE 559 0.0007
421 PHARYNGEAL SWELLING 7 0.0007
422 PHARYNGEAL OEDEMA 11 0.0007
423 LUNG DISORDER 35 0.0007
424 COELIAC DISEASE 7 0.0007
425 THROAT IRRITATION 32 0.0007
426 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
427 SEPTIC SHOCK 31 0.0007
428 LYMPHOMA 11 0.0007
429 MUSCULOSKELETAL CHEST PAIN 11 0.0007
430 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 37 0.0007
431 DEEP VEIN THROMBOSIS 46 0.0007
432 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
433 HAND FRACTURE 5 0.0007
434 THERMAL BURN 5 0.0007
435 FACIAL PARALYSIS 6 0.0007
436 COUGH 197 0.0007
437 RETINAL HAEMORRHAGE 5 0.0007
438 ROTATOR CUFF SYNDROME 9 0.0007
439 CONJUNCTIVITIS 13 0.0007
440 LIMB INJURY 19 0.0007
441 PRODUCT USE COMPLAINT 11 0.0007
442 BRAIN INJURY 7 0.0007
443 UNRESPONSIVE TO STIMULI 18 0.0007
444 PARAESTHESIA ORAL 10 0.0007
445 MOUTH SWELLING 4 0.0007
446 PRODUCT PRESCRIBING ISSUE 15 0.0007
447 SKIN WARM 4 0.0007
448 HYPOCALCAEMIA 13 0.0007
449 VASCULITIS 8 0.0007
450 ARTHRITIS 54 0.0007
451 FOOT FRACTURE 13 0.0007
452 DYSPHEMIA 3 0.0007
453 PULMONARY EMBOLISM 65 0.0007
454 MUSCLE TIGHTNESS 11 0.0007
455 NEPHROLITHIASIS 31 0.0007
456 BLOOD IRON DECREASED 8 0.0007
457 HERNIA 13 0.0007
458 PRODUCT USE IN UNAPPROVED INDICATION 166 0.0007
459 GASTROINTESTINAL DISORDER 60 0.0007
460 ROAD TRAFFIC ACCIDENT 28 0.0007
461 RENAL DISORDER 31 0.0007
462 CONTUSION 64 0.0007
463 CHROMATURIA 15 0.0007
464 HYPOAESTHESIA ORAL 10 0.0007
465 SWELLING 62 0.0007
466 NEURALGIA 16 0.0007
467 BURNING SENSATION 46 0.0007
468 HEART RATE DECREASED 23 0.0007
469 HIP FRACTURE 21 0.0007
470 SHOCK 15 0.0007
471 MENISCUS INJURY 4 0.0006
472 LARYNGEAL OEDEMA 4 0.0006
473 SYSTEMIC LUPUS ERYTHEMATOSUS 23 0.0006
474 WOUND 18 0.0006
475 PELVIC FRACTURE 5 0.0006
476 PULMONARY THROMBOSIS 7 0.0006
477 PULMONARY HAEMORRHAGE 5 0.0006
478 HYPOTENSION 128 0.0006
479 TOOTH FRACTURE 7 0.0006
480 NERVE INJURY 7 0.0006
481 APHAGIA 3 0.0006
482 BLISTER 35 0.0006
483 BLOOD CALCIUM DECREASED 7 0.0006
484 OCCUPATIONAL EXPOSURE TO PRODUCT 4 0.0006
485 HYPERHIDROSIS 80 0.0006
486 RHINITIS 5 0.0006
487 DYSPHONIA 36 0.0006
488 DRUG SPECIFIC ANTIBODY PRESENT 4 0.0006
489 DECREASED IMMUNE RESPONSIVENESS 6 0.0006
490 ASPERGILLUS INFECTION 4 0.0006
491 HYPOGAMMAGLOBULINAEMIA 4 0.0006
492 SWOLLEN TONGUE 19 0.0006
493 LIGAMENT SPRAIN 6 0.0006
494 PRURITUS GENERALISED 13 0.0006
495 FEELING ABNORMAL 144 0.0006
496 RASH MACULAR 21 0.0006
497 PREGNANCY 12 0.0006
498 SENSATION OF FOREIGN BODY 5 0.0006
499 EYELID PTOSIS 6 0.0006
500 TOOTH ABSCESS 6 0.0006
501 ERYTHEMA 121 0.0006
502 SCAR 10 0.0006
503 BLOOD SODIUM DECREASED 11 0.0006
504 PERIPHERAL COLDNESS 8 0.0006
505 RASH PAPULAR 13 0.0006
506 DIVERTICULITIS 16 0.0006
507 PYELONEPHRITIS 5 0.0006
508 LABORATORY TEST ABNORMAL 17 0.0006
509 APLASTIC ANAEMIA 3 0.0006
510 SEPSIS 64 0.0006
511 THERAPY INTERRUPTED 41 0.0006
512 APHONIA 8 0.0006
513 DEHYDRATION 76 0.0006
514 SKIN REACTION 8 0.0006
515 JOINT DISLOCATION 6 0.0006
516 ABNORMAL WEIGHT GAIN 7 0.0006
517 LUNG INFILTRATION 5 0.0006
518 BLOOD POTASSIUM DECREASED 17 0.0006
519 FEAR OF INJECTION 4 0.0006
520 COMPRESSION FRACTURE 3 0.0006
521 PAIN 342 0.0006
522 LETHARGY 32 0.0006
523 TONGUE DISORDER 4 0.0006
524 FLUID OVERLOAD 8 0.0005
525 RESPIRATORY FAILURE 40 0.0005
526 NERVE COMPRESSION 5 0.0005
527 CEREBRAL DISORDER 4 0.0005
528 RASH 234 0.0005
529 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
530 PRODUCT PREPARATION ERROR 11 0.0005
531 RASH PRURITIC 29 0.0005
532 FIBROMYALGIA 13 0.0005
533 OEDEMA 29 0.0005
534 PRESYNCOPE 13 0.0005
535 PRURITUS 204 0.0005
536 UNEVALUABLE EVENT 40 0.0005
537 ABASIA 13 0.0005
538 HAEMOGLOBIN DECREASED 54 0.0005
539 LOSS OF CONSCIOUSNESS 67 0.0005
540 FALL 174 0.0005
541 SKIN DISCOLOURATION 24 0.0005
542 C-REACTIVE PROTEIN INCREASED 19 0.0005
543 MUSCLE TWITCHING 12 0.0005
544 ATELECTASIS 5 0.0005
545 ATRIOVENTRICULAR BLOCK 4 0.0005
546 HEPATIC ENZYME INCREASED 35 0.0005
547 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
548 THERAPY NON-RESPONDER 23 0.0005
549 BONE DENSITY DECREASED 16 0.0005
550 MUSCULAR WEAKNESS 58 0.0005
551 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
552 FURUNCLE 4 0.0005
553 PNEUMOTHORAX 8 0.0005
554 GALLBLADDER DISORDER 9 0.0005
555 GINGIVAL PAIN 4 0.0005
556 MOBILITY DECREASED 36 0.0005
557 WRIST FRACTURE 6 0.0005
558 BLOOD PRESSURE FLUCTUATION 12 0.0005
559 BLOOD DISORDER 4 0.0005
560 BLOOD TEST ABNORMAL 7 0.0005
561 SENSORY LOSS 4 0.0005
562 APHASIA 15 0.0005
563 FRUSTRATION TOLERANCE DECREASED 4 0.0005
564 MUSCLE DISORDER 4 0.0005
565 DRUG LEVEL DECREASED 5 0.0005
566 MUSCLE SPASMS 90 0.0005
567 HYPERSOMNIA 14 0.0005
568 ARTHROPATHY 27 0.0005
569 LOWER RESPIRATORY TRACT INFECTION 22 0.0005
570 VENTRICULAR EXTRASYSTOLES 5 0.0005
571 CYTOMEGALOVIRUS INFECTION 8 0.0005
572 EYE DISCHARGE 5 0.0005
573 COAGULOPATHY 8 0.0005
574 SECRETION DISCHARGE 6 0.0005
575 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23 0.0005
576 BLEPHAROSPASM 3 0.0005
577 PRODUCT DOSE OMISSION ISSUE 140 0.0005
578 DISCOMFORT 29 0.0005
579 BRAIN OEDEMA 6 0.0005
580 MUSCLE ATROPHY 6 0.0005
581 ASTHENIA 178 0.0005
582 FEELING HOT 29 0.0005
583 MYALGIA 80 0.0005
584 PULMONARY FIBROSIS 9 0.0005
585 UNDERDOSE 34 0.0005
586 CARDIAC FLUTTER 3 0.0005
587 HIATUS HERNIA 6 0.0005
588 PERIPHERAL SWELLING 71 0.0005
589 SWELLING FACE 30 0.0005
590 IMMUNE SYSTEM DISORDER 6 0.0005
591 DISORIENTATION 18 0.0005
592 CORONAVIRUS INFECTION 3 0.0005
593 ABDOMINAL DISTENSION 47 0.0004
594 EYE HAEMORRHAGE 6 0.0004
595 BREAST MASS 3 0.0004
596 BRAIN FOG 7 0.0004
597 PULMONARY OEDEMA 20 0.0004
598 INFLAMMATION 23 0.0004
599 COLITIS ISCHAEMIC 3 0.0004
600 UVEITIS 6 0.0004
601 TOOTHACHE 8 0.0004
602 OSTEOMYELITIS 8 0.0004
603 ABNORMAL LOSS OF WEIGHT 3 0.0004
604 ABSCESS 7 0.0004
605 RIB FRACTURE 9 0.0004
606 CONDITION AGGRAVATED 133 0.0004
607 BRAIN NEOPLASM 4 0.0004
608 RETINAL DETACHMENT 4 0.0004
609 INCREASED TENDENCY TO BRUISE 4 0.0004
610 UROSEPSIS 4 0.0004
611 PROCEDURAL PAIN 12 0.0004
612 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
613 SOMNOLENCE 87 0.0004
614 PULMONARY HYPERTENSION 9 0.0004
615 PLEURAL EFFUSION 26 0.0004
616 HAEMATOMA 11 0.0004
617 INTESTINAL OBSTRUCTION 16 0.0004
618 ECZEMA 22 0.0004
619 SPEECH DISORDER 22 0.0004
620 FEELING JITTERY 8 0.0004
621 CONVULSION 24 0.0004
622 NEOPLASM MALIGNANT 28 0.0004
623 EYE INFLAMMATION 4 0.0004
624 PARALYSIS 6 0.0004
625 RASH ERYTHEMATOUS 20 0.0004
626 SKIN CANCER 9 0.0004
627 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
628 PAIN IN EXTREMITY 123 0.0004
629 IMPAIRED QUALITY OF LIFE 6 0.0004
630 WHITE BLOOD CELL COUNT INCREASED 16 0.0004
631 LOWER LIMB FRACTURE 8 0.0004
632 HYPOKINESIA 6 0.0004
633 LIVER FUNCTION TEST ABNORMAL 12 0.0004
634 DIZZINESS 205 0.0004
635 HEAD INJURY 13 0.0004
636 RESTLESSNESS 15 0.0004
637 ENCEPHALOPATHY 10 0.0004
638 HEPATOMEGALY 4 0.0004
639 VITREOUS FLOATERS 4 0.0004
640 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
641 SPINAL OPERATION 5 0.0004
642 INJECTION SITE EXTRAVASATION 5 0.0004
643 CATARACT 24 0.0004
644 CYST 5 0.0004
645 RHINORRHOEA 26 0.0004
646 UPPER LIMB FRACTURE 8 0.0004
647 MUSCULOSKELETAL PAIN 21 0.0004
648 HEART RATE IRREGULAR 9 0.0004
649 DRY THROAT 4 0.0004
650 ACIDOSIS 3 0.0004
651 NASAL CONGESTION 23 0.0004
652 WEIGHT DECREASED 109 0.0004
653 CEREBROVASCULAR ACCIDENT 66 0.0004
654 SEIZURE 45 0.0004
655 ANKLE FRACTURE 6 0.0004
656 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
657 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
658 SCRATCH 4 0.0004
659 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
660 DYSSTASIA 11 0.0004
661 EATING DISORDER 8 0.0004
662 BONE PAIN 22 0.0004
663 BREAST PAIN 4 0.0004
664 BODY HEIGHT DECREASED 4 0.0004
665 FLUID RETENTION 19 0.0004
666 LIVER FUNCTION TEST INCREASED 8 0.0004
667 INCORRECT DOSE ADMINISTERED 85 0.0004
668 HOT FLUSH 28 0.0004
669 THERAPY CESSATION 19 0.0004
670 SYNCOPE 37 0.0004
671 BACK DISORDER 6 0.0004
672 GASTRIC ULCER 7 0.0004
673 DECUBITUS ULCER 3 0.0004
674 NEUROPATHY PERIPHERAL 35 0.0004
675 BACK INJURY 4 0.0004
676 PRODUCT DOSE OMISSION 24 0.0004
677 GINGIVAL BLEEDING 5 0.0004
678 GASTROINTESTINAL PAIN 4 0.0004
679 RESPIRATORY ARREST 10 0.0004
680 WEIGHT INCREASED 81 0.0004
681 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
682 ARTHRALGIA 150 0.0004
683 MENTAL STATUS CHANGES 10 0.0004
684 TOOTH DISORDER 8 0.0004
685 RASH MACULO-PAPULAR 8 0.0004
686 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
687 HYPERTENSIVE CRISIS 4 0.0004
688 HAEMOPTYSIS 10 0.0004
689 COMA 17 0.0004
690 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
691 DYSURIA 13 0.0004
692 MICTURITION URGENCY 4 0.0003
693 INTERNAL HAEMORRHAGE 4 0.0003
694 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
695 RED BLOOD CELL COUNT DECREASED 10 0.0003
696 NEOPLASM 4 0.0003
697 HYPOAESTHESIA 52 0.0003
698 DIARRHOEA 224 0.0003
699 DIPLOPIA 9 0.0003
700 PRODUCT ADMINISTRATION ERROR 7 0.0003
701 PERICARDIAL EFFUSION 8 0.0003
702 DYSARTHRIA 13 0.0003
703 EYELID OEDEMA 4 0.0003
704 MOVEMENT DISORDER 11 0.0003
705 NIGHT SWEATS 11 0.0003
706 ANGIOEDEMA 15 0.0003
707 HOSPITALISATION 52 0.0003
708 ATAXIA 4 0.0003
709 BACTERAEMIA 4 0.0003
710 PRODUCT PRESCRIBING ERROR 8 0.0003
711 ABDOMINAL PAIN 78 0.0003
712 MACULAR DEGENERATION 4 0.0003
713 ACCIDENT 4 0.0003
714 EPISTAXIS 25 0.0003
715 OFF LABEL USE 292 0.0003
716 MOUTH ULCERATION 7 0.0003
717 PARAESTHESIA 52 0.0003
718 RESTLESS LEGS SYNDROME 6 0.0003
719 SKIN LESION 9 0.0003
720 IMPAIRED WORK ABILITY 7 0.0003
721 DYSPHAGIA 31 0.0003
722 CARDIOMEGALY 4 0.0003
723 HYPOKALAEMIA 15 0.0003
724 SMALL INTESTINAL OBSTRUCTION 4 0.0003
725 BLOOD GLUCOSE ABNORMAL 6 0.0003
726 PALPITATIONS 38 0.0003
727 TENDONITIS 5 0.0003
728 HEPATIC STEATOSIS 6 0.0003
729 HEPATIC CIRRHOSIS 6 0.0003
730 PRODUCT USE ISSUE 60 0.0003
731 EYE PAIN 18 0.0003
732 DISEASE RECURRENCE 15 0.0003
733 SLEEP APNOEA SYNDROME 6 0.0003
734 DEATH 269 0.0003
735 OEDEMA PERIPHERAL 38 0.0003
736 GLAUCOMA 6 0.0003
737 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
738 SKIN ULCER 8 0.0003
739 DIZZINESS POSTURAL 3 0.0003
740 HAEMORRHOIDS 6 0.0003
741 CHOKING 6 0.0003
742 AMNESIA 20 0.0003
743 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
744 ABDOMINAL PAIN UPPER 62 0.0003
745 SPINAL FRACTURE 6 0.0003
746 MALIGNANT MELANOMA 4 0.0003
747 QUALITY OF LIFE DECREASED 4 0.0003
748 RENAL IMPAIRMENT 25 0.0003
749 ILL-DEFINED DISORDER 18 0.0003
750 BLOOD BILIRUBIN INCREASED 8 0.0003
751 EYE SWELLING 11 0.0003
752 VERTIGO 18 0.0003
753 DRUG EXPOSURE DURING PREGNANCY 10 0.0003
754 CIRCULATORY COLLAPSE 5 0.0003
755 OSTEOPOROSIS 12 0.0003
756 PLATELET COUNT DECREASED 31 0.0003
757 MULTI-ORGAN FAILURE 5 0.0003
758 HUNGER 4 0.0003
759 DERMATITIS 6 0.0003
760 ABDOMINAL DISCOMFORT 48 0.0003
761 DEVICE USE ISSUE 5 0.0003
762 GENERAL PHYSICAL HEALTH DETERIORATION 33 0.0003
763 METASTASES TO LIVER 5 0.0003
764 DRUG DOSE OMISSION 47 0.0003
765 DEVICE OCCLUSION 4 0.0003
766 VISION BLURRED 39 0.0003
767 BLINDNESS UNILATERAL 4 0.0003
768 PAIN IN JAW 8 0.0003
769 SINUS TACHYCARDIA 4 0.0003
770 THIRST 5 0.0003
771 FAECES DISCOLOURED 6 0.0003
772 MYELODYSPLASTIC SYNDROME 4 0.0003
773 BIPOLAR DISORDER 3 0.0003
774 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
775 TREATMENT NONCOMPLIANCE 15 0.0003
776 ASPIRATION 3 0.0003
777 HEPATITIS 7 0.0003
778 RHEUMATOID ARTHRITIS 31 0.0003
779 DENTAL CARIES 3 0.0003
780 EXPIRED PRODUCT ADMINISTERED 9 0.0003
781 HAEMORRHAGE INTRACRANIAL 4 0.0003
782 SNEEZING 6 0.0003
783 CARDIAC DISORDER 25 0.0003
784 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
785 VISUAL IMPAIRMENT 33 0.0003
786 BALANCE DISORDER 23 0.0003
787 HEPATIC FAILURE 8 0.0003
788 LACRIMATION INCREASED 8 0.0003
789 OSTEOPENIA 4 0.0003
790 ANXIETY 75 0.0003
791 INJECTION SITE SWELLING 20 0.0003
792 ADVERSE EVENT 24 0.0003
793 JAUNDICE 7 0.0003
794 RENAL FAILURE ACUTE 11 0.0003
795 ATRIAL FIBRILLATION 25 0.0003
796 BASAL CELL CARCINOMA 4 0.0003
797 NERVOUS SYSTEM DISORDER 8 0.0003
798 RECTAL HAEMORRHAGE 11 0.0003
799 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
800 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
801 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
802 HAEMATOCRIT DECREASED 5 0.0003
803 PRODUCT QUALITY ISSUE 34 0.0003
804 SENSORY DISTURBANCE 4 0.0002
805 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
806 NERVOUSNESS 13 0.0002
807 JOINT SWELLING 30 0.0002
808 MYOCARDIAL INFARCTION 43 0.0002
809 PANCREATITIS 13 0.0002
810 INTENTIONAL DOSE OMISSION 7 0.0002
811 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
812 AGITATION 18 0.0002
813 THROMBOCYTOPENIA 27 0.0002
814 CONFUSIONAL STATE 39 0.0002
815 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
816 DECREASED APPETITE 56 0.0002
817 RENAL FAILURE 32 0.0002
818 GAIT INABILITY 8 0.0002
819 BLOOD UREA INCREASED 4 0.0002
820 INJECTION SITE PRURITUS 16 0.0002
821 DERMATITIS ALLERGIC 3 0.0002
822 PSORIASIS 31 0.0002
823 URINARY INCONTINENCE 7 0.0002
824 NEUTROPENIA 32 0.0002
825 IRRITABLE BOWEL SYNDROME 5 0.0002
826 POOR QUALITY SLEEP 5 0.0002
827 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
828 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
829 SLEEP DISORDER 16 0.0002
830 DYSMENORRHOEA 3 0.0002
831 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
832 LIVER DISORDER 10 0.0002
833 STEVENS-JOHNSON SYNDROME 5 0.0002
834 ISCHAEMIC STROKE 4 0.0002
835 DIABETES MELLITUS 17 0.0002
836 ANAEMIA 42 0.0002
837 HYPOTHYROIDISM 7 0.0002
838 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 44 0.0002
839 STOMATITIS 13 0.0002
840 GAIT DISTURBANCE 41 0.0002
841 CHOLELITHIASIS 7 0.0002
842 EYE DISORDER 7 0.0002
843 CARDIAC FAILURE CONGESTIVE 17 0.0002
844 MEMORY IMPAIRMENT 29 0.0002
845 SKIN DISORDER 7 0.0002
846 URINARY RETENTION 7 0.0002
847 CARDIOGENIC SHOCK 3 0.0002
848 ALOPECIA 41 0.0002
849 EYE PRURITUS 7 0.0002
850 BLOOD GLUCOSE DECREASED 10 0.0002
851 BRADYCARDIA 11 0.0002
852 ASCITES 6 0.0002
853 GASTRIC DISORDER 7 0.0002
854 INJECTION SITE URTICARIA 5 0.0002
855 CARDIOMYOPATHY 3 0.0002
856 DISABILITY 4 0.0002
857 HAEMORRHAGE 21 0.0002
858 IRRITABILITY 12 0.0002
859 PREMATURE BABY 6 0.0002
860 BLOOD CREATININE INCREASED 13 0.0002
861 PRODUCT PHYSICAL ISSUE 4 0.0002
862 BLOOD COUNT ABNORMAL 3 0.0002
863 FEEDING DISORDER 4 0.0002
864 DRUG DISPENSING ERROR 3 0.0002
865 TINNITUS 9 0.0002
866 HYPOPHAGIA 5 0.0002
867 CEREBRAL HAEMORRHAGE 7 0.0002
868 INJECTION SITE ERYTHEMA 24 0.0002
869 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
870 DEAFNESS 5 0.0002
871 SKIN EXFOLIATION 16 0.0002
872 DEPRESSED MOOD 10 0.0002
873 DISEASE PROGRESSION 22 0.0002
874 DYSPNOEA EXERTIONAL 7 0.0002
875 HYPOACUSIS 8 0.0002
876 PAIN OF SKIN 5 0.0002
877 FREQUENT BOWEL MOVEMENTS 5 0.0002
878 BLOOD POTASSIUM INCREASED 3 0.0002
879 COLITIS 7 0.0002
880 MENTAL DISORDER 8 0.0002
881 PRODUCT DISPENSING ERROR 4 0.0002
882 IMPAIRED HEALING 6 0.0002
883 DRUG INEFFECTIVE 240 0.0002
884 THERAPEUTIC RESPONSE DECREASED 11 0.0002
885 DRY EYE 9 0.0002
886 LEUKOPENIA 9 0.0002
887 PANCYTOPENIA 10 0.0002
888 PANCREATITIS ACUTE 4 0.0002
889 ANGER 6 0.0002
890 HAEMATURIA 6 0.0002
891 SKIN IRRITATION 8 0.0002
892 CONSTIPATION 38 0.0002
893 DEVICE BREAKAGE 7 0.0002
894 DYSKINESIA 7 0.0002
895 LUNG NEOPLASM MALIGNANT 7 0.0002
896 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
897 CARDIAC ARREST 14 0.0002
898 DRUG ERUPTION 3 0.0002
899 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
900 DEVICE ISSUE 15 0.0002
901 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
902 OSTEOARTHRITIS 7 0.0002
903 CRYING 6 0.0002
904 HYPOGLYCAEMIA 8 0.0002
905 LIVER INJURY 4 0.0002
906 INJECTION SITE MASS 6 0.0002
907 DEVICE DISLOCATION 7 0.0002
908 BREAST CANCER 15 0.0002
909 FLATULENCE 9 0.0002
910 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
911 CARDIOVASCULAR DISORDER 4 0.0002
912 ACUTE RESPIRATORY FAILURE 3 0.0002
913 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
914 SURGERY 9 0.0002
915 JOINT STIFFNESS 4 0.0002
916 OSTEONECROSIS 5 0.0002
917 GASTRITIS 4 0.0002
918 FEAR 4 0.0001
919 OCULAR HYPERAEMIA 7 0.0001
920 BLINDNESS 6 0.0001
921 NEUTROPHIL COUNT DECREASED 6 0.0001
922 MULTIPLE SCLEROSIS 7 0.0001
923 POLLAKIURIA 6 0.0001
924 CARDIO-RESPIRATORY ARREST 6 0.0001
925 INSOMNIA 38 0.0001
926 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
927 PANIC ATTACK 5 0.0001
928 CARDIAC FAILURE 11 0.0001
929 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
930 ACUTE MYOCARDIAL INFARCTION 4 0.0001
931 DYSGEUSIA 10 0.0001
932 DYSPEPSIA 13 0.0001
933 EPILEPSY 4 0.0001
934 DISTURBANCE IN ATTENTION 7 0.0001
935 FEMUR FRACTURE 4 0.0001
936 COGNITIVE DISORDER 6 0.0001
937 PLASMA CELL MYELOMA 5 0.0001
938 DEVICE MALFUNCTION 9 0.0001
939 DEPRESSION 29 0.0001
940 INJECTION SITE PAIN 39 0.0001
941 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
942 INJECTION SITE BRUISING 10 0.0001
943 INJECTION SITE HAEMORRHAGE 10 0.0001
944 DIABETIC KETOACIDOSIS 3 0.0001
945 ABORTION SPONTANEOUS 5 0.0001
946 HYPONATRAEMIA 7 0.0001
947 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
948 VISUAL ACUITY REDUCED 4 0.0001
949 AGEUSIA 3 0.0001
950 ABDOMINAL PAIN LOWER 3 0.0001
951 NEOPLASM PROGRESSION 4 0.0001
952 BREAST CANCER FEMALE 3 0.0001
953 SKIN BURNING SENSATION 8 0.0001
954 ABNORMAL DREAMS 3 0.0001
955 TREATMENT FAILURE 9 0.0001
956 MEDICATION ERROR 6 0.0001
957 DEMENTIA 3 0.0001
958 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
959 CHRONIC KIDNEY DISEASE 8 0.0001
960 ANGINA PECTORIS 3 0.0001
961 EYE IRRITATION 6 0.0001
962 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
963 INJURY 7 0.0001
964 PSORIATIC ARTHROPATHY 4 0.0001
965 DRUG ADMINISTRATION ERROR 3 0.0001
966 EMOTIONAL DISORDER 3 0.0001
967 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
968 DEVICE LEAKAGE 4 0.0001
969 COLITIS ULCERATIVE 4 0.0001
970 ARRHYTHMIA 4 0.0001
971 DRUG EFFECT INCOMPLETE 3 0.0001
972 HALLUCINATION 6 0.0001
973 FEBRILE NEUTROPENIA 5 0.0001
974 DRY MOUTH 6 0.0001
975 INJECTION SITE REACTION 5 0.0001
976 HAEMATOCHEZIA 4 0.0001
977 PRODUCT SUBSTITUTION ISSUE 4 0.0001
978 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
979 DRY SKIN 9 0.0001
980 EMOTIONAL DISTRESS 8 0.0001
981 ACNE 5 0.0001
982 BLOOD GLUCOSE INCREASED 12 0.0001
983 ACUTE KIDNEY INJURY 8 0.0001
984 OVERDOSE 10 0.0000
985 INTENTIONAL PRODUCT MISUSE 4 0.0000
986 DEVICE DIFFICULT TO USE 3 0.0000
987 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
988 DRUG INTERACTION 6 0.0000
989 TOXICITY TO VARIOUS AGENTS 6 0.0000